Soft tissue fillers are a material segment of the minimally invasive cosmetic procedure market and accounted for 2.7 million or 17% of the 16.3 million minimally invasive procedures in the USA alone in 2019. Based on our recent discovery of chemically modified Spinifex hydrogel materials, which form stable gels at concentrations <1% we aim to address the field of tissue fillers, competing with the standard materials based on hyaluronic acid or collagen. Unlike these, usually animal-derived materials, the Spinifex-based gels are fully plant-based, renewable and sustainable. Furthermore, owing to being non-animal derived, the materials are not showing the commonly observed immunogenic responses, generally present in animal tissue-derived hydrogels.

This novel technology is currently in the commercialisation phase with partners from UniQuest.

Project members

Dr Jan Lauko

Centre Manager
Advanced Spinifex Biofutures Materials Centre

Dr Alireza Hosseinmardi

Principal Research Technician
Advanced Spinifex Biofutures Materials Centre